Immune Response to the COVID-19 Vaccine

Clinical trial NCT04936997 · COMPLETED

Trial details

NCT number: NCT04936997
Sponsor: University of Arizona
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Covid19 Cancer Malignancy Vaccine Response Impaired

Start date: 2021-06-07
Primary completion: 2021-08-25
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.